Andrew D. Duckworth

发表

Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy.

G. Packham, J. Slupsky, N. Kalakonda, 2014, Blood.

c-Abl expression in chronic lymphocytic leukemia cells: clinical and therapeutic implications.

J. Cawley, J. Slupsky, Ke Lin, 2006, Cancer research.

Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development

J. Coulson, J. Slupsky, C. Figueiredo, 2020, The Journal of pathology.

Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome

A. Pettitt, I. Ringshausen, J. Slupsky, 2017, Scientific Reports.

Development of a bispecific Antibody–Drug Conjugate targeting CD7 and CD33 to treat Acute Myeloid Leukaemia

O. Schon, J. Slupsky, C. Eberlein, 2022, bioRxiv.

Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells

F. Falciani, J. Slupsky, N. Kalakonda, 2017, Scientific Reports.

Multiplexed profiling of RNA and protein expression signatures in individual cells using flow or mass cytometry

G. Nolan, P. Gherardini, J. Slupsky, 2019, Nature Protocols.

Soluble CTLA-4 raises the threshold for T-cell activation and modulates anti-tumour immunity

M. Cragg, J. Slupsky, L. Dahal, 2023, bioRxiv.

Multiplexed profiling of RNA and protein expression signatures in individual cells using flow or mass cytometry

G. Nolan, P. Gherardini, J. Slupsky, 2019, Nature Protocols.